Diabetes and Phacoemulsification Cataract Surgery : Difficulties, Risks and Potential Complications

Show full item record



Permalink

http://hdl.handle.net/10138/304919

Citation

Grzybowski , A , Kanclerz , P , Huerva , V , Ascaso , F J & Tuuminen , R 2019 , ' Diabetes and Phacoemulsification Cataract Surgery : Difficulties, Risks and Potential Complications ' , Journal of clinical medicine , vol. 8 , no. 5 , 716 . https://doi.org/10.3390/jcm8050716

Title: Diabetes and Phacoemulsification Cataract Surgery : Difficulties, Risks and Potential Complications
Author: Grzybowski, Andrzej; Kanclerz, Piotr; Huerva, Valentin; Ascaso, Francisco J.; Tuuminen, Raimo
Other contributor: University of Helsinki, Medicum



Date: 2019-05
Language: eng
Number of pages: 13
Belongs to series: Journal of clinical medicine
ISSN: 2077-0383
DOI: https://doi.org/10.3390/jcm8050716
URI: http://hdl.handle.net/10138/304919
Abstract: Diabetes mellitus is one of the most prevalent chronic diseases worldwide. Diabetic patients are at risk of developing cataract and present for surgery at an earlier age than non-diabetics. The aim of this study was to review the problems associated with cataract surgery in a diabetic patient. Corneal complications in diabetic patients include delayed wound healing, risk of developing epithelial defects or recurrent erosions due to the impairment of epithelial basement membranes and epithelial-stromal interactions. Diabetic patients present lower endothelial cell density and their endothelium is more susceptible to trauma associated with cataract surgery. A small pupil is common in diabetic patients making cataract surgery technically challenging. Finally diabetic patients have an increased risk for developing postoperative pseudophakic cystoid macular edema, posterior capsule opacification or endophthalmitis. In patients with pre-proliferative or proliferative diabetic retinopathy, diabetic macular edema or iris neovascularization adjunctive therapy such as an intravitreal anti-vascular endothelial growth factor injection, can inhibit exacerbation related to cataract surgery.
Subject: cataract surgery
diabetic macular edema
diabetes mellitus
diabetic retinopathy
phacoemulsification
POSTERIOR CAPSULE OPACIFICATION
CYSTOID MACULAR EDEMA
INTRAVITREAL BEVACIZUMAB INJECTION
CORNEAL ENDOTHELIAL MORPHOLOGY
PERIOPERATIVE GLYCEMIC CONTROL
PUPIL-DILATION
INTRACAMERAL LIDOCAINE
REFRACTIVE CHANGES
TEAR FILM
DRY EYE
3121 Internal medicine
3125 Otorhinolaryngology, ophthalmology
3126 Surgery, anesthesiology, intensive care, radiology
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
jcm_08_00716.pdf 269.0Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record